Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
Rabies virus
GlaxoSmithKline Australia Pty Ltd
Rabies virus
Registered
RABIPUR (Rab-ee-per) _Inactivated Rabies Virus Vaccine_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about RABIPUR (Inactivated Rabies Virus Vaccine). It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines, including vaccines, have risks and benefits. Your doctor has weighed the risks of you or your child having RABIPUR against the benefits they expect it will have. IF YOU HAVE ANY CONCERNS ABOUT THIS VACCINE, ASK YOUR DOCTOR, NURSE OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT RABIPUR IS USED FOR RABIPUR is a vaccine used to help prevent rabies infection in people who either • have been, or • are at risk of being bitten, licked or scratched by an animal infected with rabies virus. Rabies is a very serious infection. The rabies virus attacks the nerves and the brain. Rabies infection can be fatal if not treated as early as possible. _HOW IT WORKS_ RABIPUR works by causing your body to protect itself against rabies. The body makes substances that fight the rabies virus. They are called antibodies and circulate in the blood. If the rabies virus gets into someone who has been vaccinated against rabies, the antibodies kill the virus before it can cause damage. After vaccination your body takes several weeks to develop enough antibodies to successfully fight rabies. For vaccination against rabies you need a course of 3 to 5 injections. After this course, most people produce enough antibodies against rabies. However, as with all vaccines, 100% protection cannot be guaranteed. Further booster injections of rabies vaccine may be needed every few years to ensure enough antibodies are present. The vaccine will not give you or your child rabies. The chance of a severe reaction from RABIPUR is very small, but the risks from not being vaccinated against rabies may be very serious. BEFORE YOU ARE GIVEN RABIPUR _WHEN YOU OR YOUR CHILD_ _MUST NOT BE GIVEN RABIPUR_ DO NOT HA Đọc toàn bộ tài liệu
1 AUSTRALIAN PRODUCT INFORMATION RABIPUR (INACTIVATED RABIES VIRUS VACCINE) POWDER FOR INJECTION 1 NAME OF THE MEDICINE Inactivated Rabies Virus 2 QUALITATIVE AND QUANTITATIVE COMPOSITION RABIPUR is an inactivated rabies virus vaccine, derived from the fixed-virus strain, Flury LEP. The virus is propagated in a Purified Chick Embryo Cell (PCEC) culture, inactivated using -propiolactone and purified via centrifugation. Each 1.0 mL dose of the reconstituted vaccine contains no less than 2.5 IU of inactivated rabies virus, in accordance with the World Health Organisation requirements. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM Powder for injection. The reconstituted vaccine is clear to slightly opalescent and colourless to slightly pink. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For active immunisation against rabies virus, including: a) Pre-exposure immunisation, b) Post-exposure treatment following exposure to rabies virus. 4.2 DOSE AND METHOD OF ADMINISTRATION Recommended dosages, as outlined below, are the same for children, adolescents and adults. DOSAGE Pre-exposure Prophylaxis _Primary immunisation _ In previously unvaccinated persons, an initial course of pre-exposure prophylaxis consists of three doses (each of 1.0 mL) administered on days 0, 7 and 21 _or_ 28. 2 _Booster doses _ In persons with ongoing risk of exposure to rabies virus, the following general guidance is provided: Testing for neutralising antibodies by the Rapid Focus-Fluorescent Inhibition Test (RFFIT) at 6-month intervals is usually recommended if the risk of exposure to rabies virus is high (e. g. Laboratory staff working with rabies virus). In persons who are considered to be at continuing risk of exposure to rabies (e.g. veterinarians and their assistants, wildlife workers, hunters), a serological test should usually be performed at least every 2 years, with shorter intervals if appropriate to the perceived degree of risk. In above mentioned cases, a booster dose sh Đọc toàn bộ tài liệu